AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10505538
Drug: Moderate-intensity warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-intensity warfarin (INR 2-2.5)
Trial: 27112607
Drug: Aspirin use
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin use
Trial: 29923073
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) treatment
Trial: 29923073
Drug: PRP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP treatment
Trial: 3168311
Drug: Methimazole (MMI,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole (MMI, 40 mg/day)
Trial: 3168311
Drug: Methimazole +
RxNorm normalized name: Methimazole
DrugBank: Methimazole (DB00763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole + Sodium Ipodate (MMI + Na Ipodate, 1 g/day)
Trial: 3168311
Drug: Methimazole +
RxNorm normalized name: Methimazole
DrugBank: Methimazole (DB00763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole + Saturated Solution of Potassium Iodide (MMI + SSKI, 6 drops twice daily)
Trial: 28338191
Drug: Lidocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine spray 10 g/100 ml at 5 min before intercourse (G1)
Trial: 28338191
Drug: Tadalafil 5
RxNorm normalized name: tadalafil 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 5 mg once daily (G2)
Trial: 28338191
Drug: Tadalafil once
RxNorm normalized name: Tadalafil
DrugBank: Tadalafil (DB00820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tadalafil once daily plus lidocaine spray before planned sexual activity (G3)
Trial: 19273708
Drug: Edrecolomab (ED)
RxNorm normalized name: edrecolomab
DrugBank: Edrecolomab (DB13375)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrecolomab (ED) plus fluorouracil (FU) based therapy
Trial: 19273708
Drug: Fluorouracil (FU)
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluorouracil (FU) based therapy alone
Trial: 17363845
Drug: rosuvastatin 5-40
RxNorm normalized name: rosuvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 5-40 mg
Trial: 17363845
Drug: rosuvastatin <
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin < or = 20 mg
Trial: 17363845
Drug: rosuvastatin <
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin < or = 40 mg
Trial: 15543084
Drug: 0.4% copper
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4% copper oxide ointment
Trial: 15543084
Drug: 20% elementary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% elementary copper ointment
Trial: 9647551
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate (CPA) 25 mg/day plus testosterone enanthate (TE) 100 mg/week
Trial: 9647551
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate (CPA) 12.5 mg/day plus testosterone enanthate (TE) 100 mg/week
Trial: 8086694
Drug: Oral IgA‐IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral IgA‐IgG
Trial: 8086694
Drug: Oral Gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Gentamicin
Trial: 2722974
Drug: Brand A
RxNorm normalized name: Select Brand Aspirin 325mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brand A ranitidine tablets
Trial: 2722974
Drug: Brand B
RxNorm normalized name: Select Brand Bulk-Forming Laxative Powder for Suspension (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brand B ranitidine tablets
Trial: 9292
Drug: Alprenolol 600
RxNorm normalized name: alprenolol
DrugBank: Alprenolol (DB00866)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprenolol 600 mg daily in divided doses for six weeks
Trial: 9292
Drug: Placebo therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo therapy for six weeks
Trial: 31549424
Drug: All-on-4 rehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All-on-4 rehabilitation in the maxilla using at least two Zygoma implants (group 2)
Trial: 25656375
Drug: Group M+R
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group M+R (5ml solution containing 0.25% ropivacaine plus 5mg/kg magnesium sulphate)
Trial: 25656375
Drug: Group M
RxNorm normalized name: Coenzyme M
DrugBank: Coenzyme M (DB09110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group M (5ml solution containing 5mg/kg magnesium sulphate)
Trial: 21556447
Drug: Intramuscular methyl
RxNorm normalized name: methylal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular methyl prednisolone (40 mg) administered at two-week intervals, starting at the time of the procedure.
Trial: 11703562
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg melatonin at 18:00 hr
Trial: 11703562
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg melatonin at 20:00 hr
Trial: 11703562
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg melatonin at 21:00 hr
Trial: 10423639
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg melatonin
Trial: 9502357
Drug: Structured exercise
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured exercise prescription
Trial: 4080
Drug: Metoprolol 20
RxNorm normalized name: metoprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 20 mg t.d.s.
Trial: 4080
Drug: Metoprolol 50
RxNorm normalized name: metoprolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 50 mg t.d.s.
Trial: 28242873
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (60 IU)
Trial: 26493435
Drug: Moxifloxacin (MOX)
DrugBank: Moxifloxacin (DB00218)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moxifloxacin (MOX) therapy
Trial: 20157016
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment control group
Trial: 16984588
Drug: Preoperative proton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative proton pump inhibitor (PPI) administration for 1 week before EMR
Trial: 16984588
Drug: Endoscopic mucosal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic mucosal resection (EMR) without preoperative PPI administration
Trial: 7037868
Drug: Zomepirac sodium,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zomepirac sodium, 100 mg
Trial: 7037868
Drug: Oxycodone with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone with APC (Percodan)
Trial: 28878181
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil supplement (control)
Trial: 29287669
Drug: Bevacizumab added
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab added to neoadjuvant carboplatin‐paclitaxel chemotherapy
Trial: 30641618
Drug: Fangshuan Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fangshuan Capsule (FC), 6 pills each time, three times per day for at least 2 days before PCI operation, therapeutic course of 2 weeks.
Trial: 30641618
Drug: Fangshuan Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fangshuan Capsule (FC)
Trial: 18801111
Drug: 3.0 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0 g/day maca
Trial: 18801111
Drug: 1.5 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g/day maca
Trial: 18801111
Drug: Maca (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maca (both doses)
Trial: 16936236
Drug: Theophylline (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (400 mg/day orally)
Trial: 16936236
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) (400 mug/day inhalation)
Trial: 10939786
Drug: Perindopril treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril treatment for blood pressure reduction
Trial: 8967704
Drug: LDL apheresis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL apheresis plus simvastatin, 40 mg/d
Trial: 8967704
Drug: Simvastatin, 40
RxNorm normalized name: Simvastatin, 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin, 40 mg/d
Trial: 1548923
Drug: Heparin-coated equipment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated equipment with low systemic heparinization (heparin 5000 IU) during left heart bypass or partial cardiopulmonary bypass
Trial: 3933102
Drug: Tocainide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocainide (250 mg, single i.v. dose)
Trial: 3933102
Drug: Lidocaine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (100 mg, single i.v. dose)
Trial: 28829923
Drug: High dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dairy intake (1500 mg calcium/day)
Trial: 28829923
Drug: Low dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dairy intake (600 mg calcium/day)
Trial: 26460572
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT; Coping cat program)
Trial: 25500320
Drug: Pharmacotherapy (sertraline)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy (sertraline)
Trial: 28278599
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CBT and sertraline
Trial: 12552048
Drug: Topical anesthetic
RxNorm normalized name: Topical anesthetic
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical anesthetic applied on the contralateral forearm and foot
Trial: 11071034
Drug: 0.15 mg
RxNorm normalized name: iodine 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg clonidine
Trial: 30760204
Drug: Standard routine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard routine pharmaceutical clinical care
Trial: 22460966
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g of valacyclovir twice daily for 1 year after initial treatment with 1 g of valacyclovir 3 times daily for 1 week
Trial: 20228387
Drug: Treatment success
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment success
Trial: 20228387
Drug: Dyspnoea relief
RxNorm normalized name: Ora Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dyspnoea relief and treatment success
Trial: 18005588
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (mean blood glucose 4.4 - 6.1 mmol/L)
Trial: 18005588
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (mean blood glucose 6.7 - 8.3 mmol/L)
Trial: 6355056
Drug: Topical acyclovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical acyclovir ointment
Trial: 25929250
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment
Trial: 29185897
Drug: Psychotropic medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotropic medication with hypnotic effect (specific medications include mirtazapine and clotiapine)
Trial: 29185897
Drug: Mirtazapine and
RxNorm normalized name: Mirtazapine
DrugBank: Mirtazapine (DB00370)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mirtazapine and clotiapine (hypnotic treatments)
Trial: 22807523
Drug: RBV induction
RxNorm normalized name: RBV
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: RBV induction (2000 mg/d) plus erythropoietin β (450 IU/kg/wk)
Trial: 22807523
Drug: RBV standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBV standard dosing (1000 or 1200 mg/d)
Trial: 22807523
Drug: RBV standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBV standard dosing
Trial: 17933159
Drug: Myolaxin ointment
RxNorm normalized name: benzocaine / chloroxylenol / hydrocortisone acetate Otic Suspension [Myoxin]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myolaxin ointment
Trial: 7435798
Drug: Doxycycline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (200 mg orally once a week)
Trial: 19967420
Drug: N-acetyl-cysteine (NAC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetyl-cysteine (NAC) 1,800 mg
Trial: 19967420
Drug: Epigallocatechin gallate
RxNorm normalized name: Epigallocatechin Gallate
DrugBank: Epigallocatechin gallate (DB12116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epigallocatechin gallate (EGCG) 1,800 mg
Trial: 18008241
Drug: Standard 2-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard 2-dose IPTp (sulfadoxine-pyrimethamine)
Trial: 16247737
Drug: 700 mg
RxNorm normalized name: cystine 700 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 700 mg glycine sublingually
Trial: 12219187
Drug: Plant sterol
RxNorm normalized name: plant sterol complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant sterol ester (PSE) treatment (2.8g/d = 1.68 phytosterols)
Trial: 2254557
Drug: Placebo (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (no treatment)
Trial: 30932133
Drug: RJ group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RJ group (BCAA-enriched nutritional supplements, 2500 mg BCAA and 20 IU vitamin D, twice a day until hospital discharge)
Trial: 29781649
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy augmented by a relational focus (CBT‐R)
Trial: 27817813
Drug: Budesonide/formoterol Easyhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol Easyhaler (320/9 μg)
Trial: 27817813
Drug: Budesonide/formoterol Easyhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol Easyhaler (1280/36 μg)
Trial: 27817813
Drug: Symbicort Turbuhaler
RxNorm normalized name: Symbicort Turbuhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symbicort Turbuhaler (320/9 μg)
Trial: 27817813
Drug: Symbicort Turbuhaler
RxNorm normalized name: Symbicort Turbuhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symbicort Turbuhaler (1280/36 μg)
Trial: 31067538
Drug: Proton Pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton Pump Inhibitor (PPI) treatment
Trial: 760746
Drug: Intravenous propantheline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous propantheline bromide (15 mg)
Trial: 760746
Drug: Oral propantheline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral propantheline bromide (15 mg)
Trial: 30827722
Drug: Polyunsaturated fatty
RxNorm normalized name: omega-3 polyunsaturated fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyunsaturated fatty acids (PUFA) 3.6 g/d n-3 PUFA
Trial: 24439830
Drug: Olanzapine+Sertraline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine+Sertraline
Trial: 21720264
Drug: Atenolol-based treatment
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol-based treatment
Trial: 22499288
Drug: Losartan and
RxNorm normalized name: losartan and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan and Atenolol-based treatment
Trial: 16044063
Drug: office-based vision
FDA approved: no
EMA approved: no
PMDA approved: no
Description: office-based vision therapy/orthoptics
Trial: 16044063
Drug: office-based placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: office-based placebo vision therapy/orthoptics
Trial: 7751409
Drug: Amitriptyline (AMI)
DrugBank: Amitriptyline (DB00321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amitriptyline (AMI) and Fluoxetine (FLU) combination
Trial: 31152309
Drug: Nigella sativa
RxNorm normalized name: NIGELLA SATIVA SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nigella sativa (NS) oil capsules (1350 mg/day)
Trial: 18082737
Drug: Metformin tablets
RxNorm normalized name: metformin Oral Tablet
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin tablets
Trial: 28826745
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of 0.5% ropivacaine for 96 hours
Trial: 28826745
Drug: Sham infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sham infusion (normal saline) for 96 hours
Trial: 25351453
Drug: Glutamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine (10 g 3 times a day)
Trial: 23988855
Drug: α-Lipoic acid
RxNorm normalized name: α-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-Lipoic acid (ALA) treatment for 2 days (600 mg orally three times a day before and after coronary catheterization, n = 100)
Trial: 21481742
Drug: Rufinamide (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rufinamide (up to 45 mg/kg daily) as adjunctive therapy
Trial: 19686530
Drug: Extended treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended treatment with varenicline
Trial: 15304151
Drug: ABMK treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABMK treatment (Agaricus blazei Murill Kyowa)
Trial: 8282361
Drug: Nitrendipine 10
RxNorm normalized name: nitrendipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 10 mg given at 6 AM on awakening
Trial: 8282361
Drug: Nitrendipine 10
RxNorm normalized name: nitrendipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 10 mg given at 8:30 AM after breakfast
Trial: 8282361
Drug: Nitrendipine 10
RxNorm normalized name: nitrendipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 10 mg given at 6 PM after supper
Trial: 31687205
Drug: No-treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment
Trial: 18682739
Drug: 8-week primaquine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-week primaquine (PQ) regimen (0.75 mg/kg/week)
Trial: 18682739
Drug: 14-day primaquine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-day primaquine (PQ) regimen (0.5 mg/kg/day)
Trial: 18682739
Drug: Placebo (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (once weekly 8-week)
Trial: 10809915
Drug: Intracutaneous injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracutaneous injections of botulinum toxin (Botox(R)) 2 U/4 cm2
Trial: 9863158
Drug: Fluvoxamine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (100 mg.d‐1)
Trial: 3523396
Drug: Imipramine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (100 mg)
Trial: 6125636
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard medication)
Trial: 27494089
Drug: Ofatumumab plus
RxNorm normalized name: Ofatumumab
DrugBank: Ofatumumab (DB06650)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ofatumumab plus chlorambucil (oral chlorambucil 10 mg/m2 on Days 1-7 of a 28-day cycle; ofatumumab: Cycle 1: 300 mg on Day 1 and 1000 mg on Day 8; subsequent cycles: 1000 mg Day 1 for 3-12 cycles)
Trial: 27494089
Drug: Chlorambucil monotherapy
RxNorm normalized name: Chlorambucil
DrugBank: Chlorambucil (DB00291)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorambucil monotherapy (oral chlorambucil 10 mg/m2 on Days 1-7 of a 28-day cycle)
Trial: 24120714
Drug: prednisolone 2.5
RxNorm normalized name: prednisolone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prednisolone 2.5 mg
Trial: 24120714
Drug: prednisolone 5
RxNorm normalized name: prednisolone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prednisolone 5 mg
Trial: 24120714
Drug: prednisolone 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prednisolone 7.5 mg
Trial: 24120714
Drug: prednisolone 10
RxNorm normalized name: prednisolone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prednisolone 10 mg
Trial: 24120714
Drug: prednisolone 15
RxNorm normalized name: prednisolone 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prednisolone 15 mg
Trial: 17572346
Drug: Atropine 1%
RxNorm normalized name: Isopto Atropine 1% Ophthalmic Solution
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine 1% solution (N = 134)
Trial: 14747205
Drug: Insulin resistance
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin resistance and beta-cell function
Trial: 7578765
Drug: Meropenem 500
RxNorm normalized name: meropenem 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 500 mg IV every 8 hours
Trial: 7578765
Drug: Imipenem/cilastatin 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem/cilastatin 500 mg IV every 6 hours